Your browser doesn't support javascript.
loading
Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects.
Guffanti, Monica; Caumo, Andrea; Galli, Laura; Bigoloni, Alba; Galli, Andrea; Dagba, Geneviéve; Danise, Anna; Luzi, Livio; Lazzarin, Adriano; Castagna, Antonella.
Affiliation
  • Guffanti M; Clinic of Infectious Diseases, San Raffaele Scientific Institute, Via Stamira d'ancona 20, 20127 Milan, Italy. guffanti.monica@hsr.it
Eur J Endocrinol ; 156(4): 503-9, 2007 Apr.
Article in En | MEDLINE | ID: mdl-17389467
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Pyridines / Blood Glucose / HIV Infections / HIV-1 / HIV Protease Inhibitors Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2007 Document type: Article Affiliation country: Italia
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Pyridines / Blood Glucose / HIV Infections / HIV-1 / HIV Protease Inhibitors Type of study: Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2007 Document type: Article Affiliation country: Italia